Jamie Kasuboski
Vice-President - OMX Ventures

Jamie is a Vice President at OMX Ventures.

He previously focused on early-stage Biotech investing and company creation while at RA Capital and served on the board of Enara bio, Avilar Therapeutics and Endor Therapeutics. Before joining RA he was a Director at Boehringer Ingelheim Venture Fund and served as a Board Director of both Tilos Therapeutics (acquired Merck & Co.) and Rewind Therapeutics.

Jamie holds a BS in Biology with a minor in Chemistry from Hillsdale College and a PhD in Molecular and Cellular Biology from the University of Notre Dame.